This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES Europe: Oligonucleotide and Peptide Therapeutics
12 - 14 Nov 2024
Hamburg Congress CentreHamburg, Germany

Yi Yang, PhD
Principal Scientist at Ferring Pharmaceuticals A/S
Speaker

Profile

Dr. Yi Yang obtained his Ph.D degree from Bielefeld University, Germany, in 2008 under the guidance of Prof. Dr. Norbert Sewald. He has been working at Lonza in Visp/Switzerland as a process chemist for peptide API process development, optimization, innovation, and GMP manufacturing. He is now working at Ferring Pharmaceuticals A/S as a lead scientist, focusing on the peptide API process development, optimization, innovation, and the management of the GMP manufacturing. Dr. Yi Yang has abundant experiences on peptide synthesis, side reaction/impurity analysis from both API manufacturing and formulation, process development/optimization/validation through QbD (Quality-by-Design), innovation, and GMP manufacturing including genotoxic impurity management, tech-transfer, risk assessment, operation, and regulatory management. Dr. Yi Yang holds a Lean-Six-Sigma Black Belt Certificate and published many articles as well as a monograph of “Side Reactions in Peptide Synthesis” (Academic Press).

Agenda Sessions

  • Improving Efficiencies in Peptide API Process Development

    16:45